BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16352563)

  • 1. Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells.
    Efferson CL; Tsuda N; Kawano K; Nistal-Villán E; Sellappan S; Yu D; Murray JL; García-Sastre A; Ioannides CG
    J Virol; 2006 Jan; 80(1):383-94. PubMed ID: 16352563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene.
    Efferson CL; Schickli J; Ko BK; Kawano K; Mouzi S; Palese P; García-Sastre A; Ioannides CG
    J Virol; 2003 Jul; 77(13):7411-24. PubMed ID: 12805440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.
    Ferko B; Stasakova J; Romanova J; Kittel C; Sereinig S; Katinger H; Egorov A
    J Virol; 2004 Dec; 78(23):13037-45. PubMed ID: 15542655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
    Efferson CL; Kawano K; Tsuda N; Palese P; García-Sastre A; Ioannides CG
    Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
    Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
    J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N Terminus-Truncated NS1 Proteins of Influenza A Virus in Inhibiting IRF3 Activation.
    Kuo RL; Li LH; Lin SJ; Li ZH; Chen GW; Chang CK; Wang YR; Tam EH; Gong YN; Krug RM; Shih SR
    J Virol; 2016 May; 90(9):4696-4705. PubMed ID: 26912617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus evades innate and adaptive immunity via the NS1 protein.
    Fernandez-Sesma A; Marukian S; Ebersole BJ; Kaminski D; Park MS; Yuen T; Sealfon SC; García-Sastre A; Moran TM
    J Virol; 2006 Jul; 80(13):6295-304. PubMed ID: 16775317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon.
    Dauber B; Schneider J; Wolff T
    J Virol; 2006 Dec; 80(23):11667-77. PubMed ID: 16987984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza.
    Geiss GK; Salvatore M; Tumpey TM; Carter VS; Wang X; Basler CF; Taubenberger JK; Bumgarner RE; Palese P; Katze MG; García-Sastre A
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10736-41. PubMed ID: 12149435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains.
    Wang X; Basler CF; Williams BR; Silverman RH; Palese P; García-Sastre A
    J Virol; 2002 Dec; 76(24):12951-62. PubMed ID: 12438621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinctive features of influenza virus infection of dendritic cells.
    Bender A; Albert M; Reddy A; Feldman M; Sauter B; Kaplan G; Hellman W; Bhardwaj N
    Immunobiology; 1998 Mar; 198(5):552-67. PubMed ID: 9561373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective cross-reactive epitope on the nonstructural protein NS1 of influenza A virus.
    Saikh KU; Tamura M; Kuwano K; Dai LC; West K; Ennis FA
    Viral Immunol; 1993; 6(4):229-36. PubMed ID: 7513168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response.
    Kotelkin A; Belyakov IM; Yang L; Berzofsky JA; Collins PL; Bukreyev A
    J Virol; 2006 Jun; 80(12):5958-67. PubMed ID: 16731934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.
    Wang X; Li M; Zheng H; Muster T; Palese P; Beg AA; García-Sastre A
    J Virol; 2000 Dec; 74(24):11566-73. PubMed ID: 11090154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncation of the NS1 protein converts a low pathogenic avian influenza virus into a strong interferon inducer in duck cells.
    Soubies SM; Volmer C; Guérin JL; Volmer R
    Avian Dis; 2010 Mar; 54(1 Suppl):527-31. PubMed ID: 20521689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis.
    Salvatore M; Basler CF; Parisien JP; Horvath CM; Bourmakina S; Zheng H; Muster T; Palese P; García-Sastre A
    J Virol; 2002 Feb; 76(3):1206-12. PubMed ID: 11773396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of a dendritic cell-based tumour vaccine by an influenza virus.
    Sachet M; Friedl J; Hassler M; Ploder M; Stary G; Stift A; Bergmann M
    Eur J Clin Invest; 2009 Nov; 39(11):1000-9. PubMed ID: 19807781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
    Min JY; Li S; Sen GC; Krug RM
    Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
    Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W
    Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
    Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
    J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.